(46 days)
91 DKB
91 DKB
No
The device description and intended use clearly define the product as calibrators and controls for drug-of-abuse assays. There is no mention of any computational or analytical capabilities beyond providing known concentrations of analytes for calibration and quality control. The "Mentions AI, DNN, or ML" section explicitly states "Not Found".
No.
The device is used for calibration and quality control of drug-of-abuse assays, not for diagnosing, treating, or preventing disease.
No
This device is a calibrator/control material used for drug-of-abuse assays, not a diagnostic device itself. It helps ensure the accuracy of diagnostic tests but does not directly diagnose conditions.
No
The device description clearly states the device is provided as "ready-to-use liquids in a human urine matrix," indicating it is a physical substance, not software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states that the device is used in the "calibration of the Emit II Plus drugs-of-abuse assays" and as "quality control materials." These are typical functions of IVD devices used in laboratory settings to ensure the accuracy and reliability of diagnostic tests.
- Device Description: The description details the composition of the calibrators/controls, which contain specific drug analytes in a human urine matrix. This indicates that the device is designed to be used in vitro (outside the body) with biological samples (urine) to assess the performance of diagnostic assays.
- Classification Name: The classification name "Clinical Toxicology Calibrator, 91 DKB" is a specific regulatory classification for devices used in clinical toxicology testing, which falls under the umbrella of IVDs.
- Use with Assays: The device is intended to be used with "Emit II Plus assays for detecting" various drugs. This clearly links the device to diagnostic testing procedures.
The information provided strongly indicates that this device is designed and intended for use in a laboratory setting to support the performance and accuracy of in vitro diagnostic tests for drugs of abuse.
N/A
Intended Use / Indications for Use
The Emit Calibrator/Controls are used in the callbration of the Emit II Plus drugs-of-abuse assays. These standards may also be used as quality control materials based upon specified assay cutoff levels. The Emit Calibrator/Controls are used for the Emit II Plus Barbiturate, Benzodiazepine, Cannabinoid, Cocaine Metabolite, Methadone, Methaqualone, Mononclonal Amphetamine/Methamphetamine, Opiates, Phencyclidine, and Propoxyphene Assays.
Product codes
DKB, DIF
Device Description
The device is the Emit Calibrators' Controls , Lavels 0-5. The common or usual name is calibrators and/ or controls. The classification name is Clinical Toxicology Calibrator, 91 DKB. The Emit Calibrators/Controls contain various combinations of the following drugs at varying concentrations: benzoyecgonine, lormetazepam, methamphetamine, methaqualone, morphine, 11-delta 9-THC-9-COOH, phencyclidine, propoxyphene and secobarbital. They are intended to be used with the following respective Emit II Plus assays for detecting: eocaine metabolite, benzodiazepines, methadone, amphetamines, methaqualone, opiates, cannabinoids, phencyclidine, propoxyphene and barbiturates. The Emit Calibrators Controls are provided as ready-to-use liquids in a human urine matrix and they have characteristics common to a variety of commercially available calibrators and/or controls intended for use with assays for detecting drugs of-abuse. The do not have any expecially unique technical characteristics.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Studies have shown that none of the analytes cross react or otherwise interfere with the use of any of the Emit II Plus assays for which these products are intended and that the products are sufficiently stable for their intended uses.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Emit Calibrator Level O, Emit Calibrators A Level 1 and 2 and Emit Calibrators B Level 1 and 2.
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.3200 Clinical toxicology calibrator.
(a)
Identification. A clinical toxicology calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. A clinical toxicology calibrator can be a mixture of drugs or a specific material for a particular drug (e.g., ethanol, lidocaine, etc.). (See also § 862.2 in this part.)(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
DEC 2 1 1999
DADE BEHRING
P.2
SYVA COMPANY P.O. Box 49013 San Jose, CA 95161-9013
3403 Yerba Buena Road San Jose, CA 95135 Tel: +1 (408) 239-2000
510 (k) SUMMARY
This summary of $10(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21CFR 807.92.
The assigned 510(k) number is:
The device is the Emit Calibrators' Controls , Lavels 0-5. The common or usual name is calibrators and/ or controls. The classification name is Clinical Toxicology Calibrator, 91 DKB.
The device is substantially equivalent to the following: Emit Calibrator Level O, Emit Calibrators A Level 1 and 2 and Emit Calibrators B Level 1 and 2.
The Emit Calibrators/Controls contain various combinations of the following drugs at varying concentrations: benzoyecgonine, lormetazepam, methamphetamine, methaqualone, morphine, 11-delta 9-THC-9-COOH, phencyclidine, propoxyphene and secobarbital. They are intended to be used with the following respective Emit II Plus assays for detecting: eocaine metabolite, benzodiazepines, methadone, amphetamines, methaqualone, opiates, cannabinoids, phencyclidine, propoxyphene and barbiturates.
The Emit Calibrators Controls are provided as ready-to-use liquids in a human urine matrix and they have characteristics common to a variety of commercially available calibrators and/or controls intended for use with assays for detecting drugs of-abuse. The do not have any expecially unique technical characteristics.
Where applicable, calibrators include concentrations of analytes that are required by the US Substance Abuse and Mental Health Services Administration (SAMHSA) for detecting drugs-ofabuse.
Nominal concentrations of each analyte are traceable to confirmation by GC/MS.
Studies have shown that none of the analytes cross react or otherwise interfere with the use of any of the Emit II Plus assays for which these products are intended and that the products are sufficiently stable for their intended uses.
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular arrangement of text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". Inside the circle is a stylized image of an eagle with three lines representing its wings and head.
DEC 2 1 1999
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
Mr. Paul L. Rogers Jr. Senior Manager, Regulatory Affairs Syva Company 3403 Yerba Buena Road San Jose, California 95135
Re: K993755 Trade Name: Emit® Calibrator/Control Level 0 Emit® Calibrator/Control Level 1 Emit® Calibrator/Control Level 2 Emit® Calibrator/Control Level 3 Emit® Calibrator/Control Level 4 Emit® Calibrator/Control Level 5 Regulatory Class: II Product Code: DKB Regulatory Class: I Product Code: DIF Dated: November 4, 1999 Received: November 5, 1999
Dear Mr. Wells:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic OS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
2
Page 2
Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88), this device may require a CLIA complexity categorization. To determine if it does, you should contact the Centers for Disease Control and Prevention (CDC) at (770) 488-7655.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrl/dsma/dsmamain.html".
Sincerely yours,
Steven Putman
Steven I. Gutman, M.D, M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
510(k) Number (if known): K993755
Device Name:
Emit® Calibrator/Control Level 0 Emit® Calibrator/Control Level 1 Emit® Calibrator/Control Level 2 Emit® Calibrator/Control Level 3 Emit® Calibrator/Control Level 4 Emit® Calibrator/Control Level 5
Indications for Use:
The Emit Calibrator/Controls are used in the callbration of the Emit II Plus drugs-of-abuse assays. These standards may also be used as quality control materials based upon specified assay cutoff levels. The Emit Calibrator/Controls are used for the Emit II Plus Barbiturate, Benzodiazepine, Cannabinoid, Cocaine Metabolite, Methadone, Methaqualone, Mononclonal Amphetamine/Methamphetamine, Opiates, Phencyclidine, and Propoxyphene Assays.
Note: The above listed assays are currently in the process of being filed for 510(k) clearance,
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter Use
(Optional Format 1-2-96)
Dean Cooper
Division Sign-Off) on of Clinical Laboratory Devices 55